PC
ZVSAW

Periscope Capital’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Periscope Capital’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-125,800
Closed -$15K – 1033
2022
Q3 		$15K Sell
125,800
-78,200
-38% -$10.1K ﹤0.01% 943
2022
Q2 		$22K Buy
+204,000
New +$35.5K ﹤0.01% 923

Periscope Capital's ZVSAW Position: Q4 2022 in Review

Periscope Capital sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 125,800 shares — an estimated $15K sold.

Periscope Capital first reported a position in ZVSAW in Q2 2022 and held it in 2 quarters. The position peaked at $22K in Q2 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • Periscope Capital reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • Periscope Capital sold 125,800 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $15K.
  • Periscope Capital first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q2 2022 and held it in 2 quarters.
  • Periscope Capital's ZyVersa Therapeutics, Inc. Warrants position peaked at $22K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Periscope Capital's 13F filing for Q4 2022, filed 13 Feb 2023.